GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XSWX:MRK) » Definitions » Price-to-Tangible-Book

Merck (XSWX:MRK) Price-to-Tangible-Book : (As of Apr. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Merck Price-to-Tangible-Book?

As of today (2024-04-26), Merck's share price is CHF400.00. Merck's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was CHF-0.55. Hence, Merck's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Merck's Price-to-Tangible-Book or its related term are showing as below:

XSWX:MRK' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 10.07   Med: 33.39   Max: 357.14
Current: 357.14

During the past 13 years, Merck's highest Price to Tangible Book Ratio was 357.14. The lowest was 10.07. And the median was 33.39.

XSWX:MRK's Price-to-Tangible-Book is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.36 vs XSWX:MRK: 357.14

A closely related ratio is called PB Ratio. As of today, Merck's share price is CHF400.00. Merck's Book Value per Sharefor the quarter that ended in Dec. 2023 was CHF12.81. Hence, Merck's P/B Ratio of today is 31.24.


Merck Price-to-Tangible-Book Historical Data

The historical data trend for Merck's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Price-to-Tangible-Book Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 241.25 -

Merck Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 241.25 - - - -

Competitive Comparison of Merck's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Merck's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Merck's Price-to-Tangible-Book falls into.



Merck Price-to-Tangible-Book Calculation

Merck's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=400.00/-0.554
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Merck Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Merck's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (XSWX:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (XSWX:MRK) Headlines